Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 1
2002 5
2003 8
2004 14
2005 24
2006 19
2007 23
2008 28
2009 23
2010 26
2011 21
2012 26
2013 24
2014 33
2015 31
2016 45
2017 33
2018 32
2019 50
2020 36
2021 36
2022 34
2023 29
2024 31

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

535 results

Results by year

Filters applied: . Clear all
Page 1
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, Vierling JM, Levy C, Kremer AE, Zigmond E, Andreone P, Gordon SC, Bowlus CL, Lawitz EJ, Aspinall RJ, Pratt DS, Raikhelson K, Gonzalez-Huezo MS, Heneghan MA, Jeong SH, Ladrón de Guevara AL, Mayo MJ, Dalekos GN, Drenth JPH, Janczewska E, Leggett BA, Nevens F, Vargas V, Zuckerman E, Corpechot C, Fassio E, Hinrichsen H, Invernizzi P, Trivedi PJ, Forman L, Jones DEJ, Ryder SD, Swain MG, Steinberg A, Boudes PF, Choi YJ, McWherter CA; ENHANCE Study Group*. Hirschfield GM, et al. Among authors: drenth jph. Hepatology. 2023 Aug 1;78(2):397-415. doi: 10.1097/HEP.0000000000000395. Epub 2023 Apr 6. Hepatology. 2023. PMID: 37386786 Free PMC article. Clinical Trial.
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.
Nevens F, Andreone P, Mazzella G, Strasser SI, Bowlus C, Invernizzi P, Drenth JP, Pockros PJ, Regula J, Beuers U, Trauner M, Jones DE, Floreani A, Hohenester S, Luketic V, Shiffman M, van Erpecum KJ, Vargas V, Vincent C, Hirschfield GM, Shah H, Hansen B, Lindor KD, Marschall HU, Kowdley KV, Hooshmand-Rad R, Marmon T, Sheeron S, Pencek R, MacConell L, Pruzanski M, Shapiro D; POISE Study Group. Nevens F, et al. N Engl J Med. 2016 Aug 18;375(7):631-43. doi: 10.1056/NEJMoa1509840. N Engl J Med. 2016. PMID: 27532829 Free article. Clinical Trial.
Reply.
Goltstein LCMJ, Drenth JPH. Goltstein LCMJ, et al. Among authors: drenth jph. Gastroenterology. 2024 Oct;167(5):1052-1053. doi: 10.1053/j.gastro.2024.06.004. Epub 2024 Jun 14. Gastroenterology. 2024. PMID: 38878801 No abstract available.
Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study): A Multicenter Randomized Controlled Trial.
Goltstein LCMJ, Grooteman KV, Bernts LHP, Scheffer RCH, Laheij RJF, Gilissen LPL, Schrauwen RWM, Talstra NC, Zuur AT, Braat H, Hadithi M, Brouwer JT, Nagengast WB, Oort FA, Tenthof van Noorden J, Kievit W, van Geenen EJM, Drenth JPH. Goltstein LCMJ, et al. Among authors: drenth jph. Gastroenterology. 2024 Apr;166(4):690-703. doi: 10.1053/j.gastro.2023.12.020. Epub 2023 Dec 28. Gastroenterology. 2024. PMID: 38158089 Free article. Clinical Trial.
An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis.
Snijders RJALM, Stoelinga AEC, Gevers TJG, Pape S, Biewenga M, Tushuizen ME, Verdonk RC, de Jonge HJM, Vrolijk JM, Bakker SF, Vanwolleghem T, de Boer YS, Baven Pronk MAMC, Beuers U, van der Meer AJ, Gerven NMFV, Sijtsma MGM, van Eijck BC, van IJzendoorn MC, van Herwaarden M, van den Brand FF, Korkmaz KS, van den Berg AP, Guichelaar MMJ, Levens AD, van Hoek B, Drenth JPH; Dutch Autoimmune Hepatitis Working Group. Snijders RJALM, et al. Among authors: drenth jph. J Hepatol. 2024 Apr;80(4):576-585. doi: 10.1016/j.jhep.2023.11.032. Epub 2023 Dec 14. J Hepatol. 2024. PMID: 38101756 Free article. Clinical Trial.
UEG journal's editorial team.
Drenth JPH, Pawlak KM. Drenth JPH, et al. United European Gastroenterol J. 2022 Dec;10(10):1041-1043. doi: 10.1002/ueg2.12340. Epub 2022 Nov 24. United European Gastroenterol J. 2022. PMID: 36424368 Free PMC article. No abstract available.
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group.
Pape S, Snijders RJALM, Gevers TJG, Chazouilleres O, Dalekos GN, Hirschfield GM, Lenzi M, Trauner M, Manns MP, Vierling JM, Montano-Loza AJ, Lohse AW, Schramm C, Drenth JPH, Heneghan MA; International Autoimmune Hepatitis Group (IAIHG) collaborators(‡). Pape S, et al. Among authors: drenth jph. J Hepatol. 2022 Apr;76(4):841-849. doi: 10.1016/j.jhep.2021.12.041. Epub 2022 Jan 20. J Hepatol. 2022. PMID: 35066089 Free article.
Laparoscopy in cholecysto-choledocholithiasis.
van Dijk AH, Lamberts M, van Laarhoven CJ, Drenth JP, Boermeester MA, de Reuver PR. van Dijk AH, et al. Best Pract Res Clin Gastroenterol. 2014 Feb;28(1):195-209. doi: 10.1016/j.bpg.2013.11.015. Epub 2013 Dec 6. Best Pract Res Clin Gastroenterol. 2014. PMID: 24485266 Review.
The pathophysiology of polycystic liver disease.
Duijzer R, Boerrigter MM, Gevers TJG, Drenth JPH. Duijzer R, et al. Among authors: drenth jph. J Hepatol. 2024 Jun;80(6):981-983. doi: 10.1016/j.jhep.2023.12.027. Epub 2024 Apr 9. J Hepatol. 2024. PMID: 38599980 Review. No abstract available.
Reply.
Pape S, Gevers TJG, Drenth JPH. Pape S, et al. Among authors: drenth jph. Clin Gastroenterol Hepatol. 2020 Jul;18(8):1897-1898. doi: 10.1016/j.cgh.2020.01.038. Epub 2020 Feb 1. Clin Gastroenterol Hepatol. 2020. PMID: 32017986 No abstract available.
535 results